Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Northwest Biotherapeutics (NWBO) FCF Payout Ratio: 2009-2013

Historic FCF Payout Ratio for Northwest Biotherapeutics (NWBO) over the last 2 years, with Dec 2013 value amounting to -0.01.

  • Northwest Biotherapeutics' FCF Payout Ratio rose 13.36% to -0.01 in Q4 2013 from the same period last year, while for Dec 2013 it was -0.01, marking a year-over-year increase of 60.36%. This contributed to the annual value of 0.01 for FY2009, which is N/A change from last year.
  • Latest data reveals that Northwest Biotherapeutics reported FCF Payout Ratio of -0.01 as of Q4 2013, which was down 0.52% from -0.01 recorded in Q3 2013.
  • In the past 5 years, Northwest Biotherapeutics' FCF Payout Ratio registered a high of 1.28 during Q3 2012, and its lowest value of -0.76 during Q2 2010.
  • In the last 3 years, Northwest Biotherapeutics' FCF Payout Ratio had a median value of -0.01 in 2012 and averaged 0.17.
  • Per our database at Business Quant, Northwest Biotherapeutics' FCF Payout Ratio spiked by 12,161.48% in 2012 and then plummeted by 100.58% in 2013.
  • Quarterly analysis of 5 years shows Northwest Biotherapeutics' FCF Payout Ratio stood at 0.97 in 2009, then slumped by 33.81% to -0.76 in 2010, then soared by 98.54% to -0.01 in 2011, then spiked by 12,161.48% to -0.01 in 2012, then grew by 13.36% to -0.01 in 2013.
  • Its last three reported values are -0.01 in Q4 2013, -0.01 for Q3 2013, and 0.15 during Q2 2013.